In order to investigate the 4-hydroxy-1,2,5-oxadiazol-3-yl moiety as a carboxylic acid bioisoster at ionotropic glutamate receptors (iGluRs), a series of acidic R-aminocarboxylic acids in which the distal carboxy group was replaced by the 4-hydroxy-1,2,5-oxadiazol-3-yl group was synthesized. Ionization constants were determined. All target compounds, except the Asp analogue 12, were resolved using chiral HPLC. Whereas 12 showed good affinity exclusively at NMDA receptors, the Glu analogue, (þ)-10, was an unselective, though potent AMPA receptor preferring agonist (EC 50 = 10 μM at iGluR2) showing only low stereoselectivity. The two higher Glu homologues, (þ)-15 and (þ)-18, turned out to be weak agonists at iGluR2 as well as weak antagonists at NR1/NR2A, whereas the corresponding (-)isomers were selective NR1/NR2A antagonists with somewhat higher potency. The results proved the 4-hydroxy-1,2,5-oxadiazol-3-yl moiety to be a useful bioisoster at all three classes of iGluRs, capable of being integrated into agonists as well as antagonists.
Introduction
(S)-Glutamate ((S)-Glu, a Figure 1 ) plays a major role in the transmission of excitatory signals in the central nervous system (CNS) and is implicated in epilepsy, pain, memory, excitotoxicity, and brain development. 1 It mediates its actions through two classes of receptors (GluRs). The first class consists of ionotropic glutamate receptors (iGluRs) that are classified according to their selective agonists into NMDA (N-methyl-D-aspartate), AMPA ((RS)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid, 1, Figure 1 ) and KA (kainic acid) receptors. The second class consists of metabotropic glutamate receptors (mGluRs) that are divided into three groups (I, II, III) each containing at least two subtypes. The vast majority of both iGluR and mGluR subtypes are considered interesting therapeutic targets for the treatment of a number of neurologic and psychiatric diseases. 1, 2 Specific agonists and antagonists are necessary in order to characterize the physiological roles of the individual receptors.
In the design of selective receptor ligands, isosteric replacement of moieties in a lead structure is one of the most frequently used approaches. [3] [4] [5] [6] [7] This approach should be carried out taking into account that a particular isosteric group proven to be a bioisoster in one lead compound may not necessarily be successful in another. In the designing of mimetics of endogenous acidic amino acids, a number of bioisosteric replacements of the carboxylic group have been described 8 and especially 3hydroxyisoxazol-4-yl has been a well studied example at iGluRs. 9 Quite recently, another hydroxy-substituted heterocycle, 4-hydroxy-1,2,5-thiadiazol-3-yl, was substituted for the distal carboxylic group in Glu to give 2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propionic acid (TDPA, 2, Figure 1 ) which shows a preference for the AMPA subtype of iGluRs. 10 Recently, we proposed the 4-hydroxy-1,2,5-oxadiazol-3-yl moiety as a potential bioisoster of the COOH function and we explored the possibility of obtaining biomimetics of γ-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the CNS. This approach gave rise to compounds with partial agonist profiles at GABA A receptors. 11 In this paper we describe the synthesis, ionization properties, resolution, and molecular pharmacological characterization at native and recombinant 
Results and Discussion
Chemistry. The synthetic pathways used to prepare the target compounds 10, 12, 15, 18 are reported in Scheme 1. The strict analogue 10 of Glu was prepared starting from (4hydroxy-1,2,5-oxadiazol-3-yl)acetic acid (3) that was transformed into the corresponding ethyl ester by action of gaseous HCl in dry ethanol. The ester was purified by flash chromatography and immediately treated with benzyl bromide in acetone in the presence of K 2 CO 3 to afford the ester 4. Basic hydrolysis of 4 afforded 4a that by KMnO 4 lateral chain oxidative demolition produced the benzyloxyl substituted 1,2,5-oxadiazolecarboxylic acid 5. Methyl ester 6 was obtained from 5 in dry methanol solution saturated with gaseous HCl. Reduction of the ester function of 6 carried out with NaBH 4 in tetrahydrofuran (THF) yielded the alcohol 7. The related bromo derivative 8 was obtained by treating 7 with N-bromosuccinimide (NBS) in THF in the presence of Ph 3 P. A THF solution of this last intermediate was allowed to react with diethyl [(tert-butoxycarbonyl)amino]malonate and NaH mineral oil dispersion to give 9. Pd/C, H 2 reduction of 9 afforded 9a that was refluxed in HBr water solution to afford, after ion exchange chromatography, the racemic mixture 10. Synthesis of the racemic mixture of 12 was carried out by nitrosation of the active methylene of 4 and subsequent reduction of oxime 11 with Pd/C, H 2 followed by immediate HCl hydrolysis of the intermediate ester 11a. To prepare the racemic mixture 15, the intermediate 4 was transformed into the alcohol 13 by action of LiAlH 4 in THF. Alcohol 13, treated with triflic anhydride (Tf 2 O) in the presence of 2,6-lutidine afforded the corresponding trifluoromethanesulfonate, which was quickly purified by flash chromatography and immediately allowed to react with diethyl [(tert-butoxycarbonyl)amino]malonate and NaH mineral oil dispersion to give 14. This last product, treated under the same conditions used to prepare 10 from 9, gave rise to the final compound 15 through the intermediate formation of 14a. Synthesis of 17 was carried out by treating alcohol 16 in the same conditions used to prepare 14 from 13. Treatment of 17 with NaOH in DMSO induced nucleophilic substitution of the phenylsulfonyl group with consequent formation of the corresponding sulfinic acid and partial hydrolysis of ethyl ester moieties. Treatment of this mixture with Oxone at controlled pH, in order to oxidate phenylsulfinic acid to the more acidic sulfonic acid, and subsequent extraction with diethyl ether of the resulting mixture gave a crude material that was refluxed in aqueous HBr to yield target compound 18.
Ionization Constants. The ionization constants (pK a values) for the final compounds 10, 12, 15, 18 were obtained by potentiometric titration using a GLpKa apparatus. The pK a values are collected in Table 1 . The products show three dissociation constants in the ranges pK a1 = 1.88-2.48, pK a2 = 3.37-3.69, and pK a3 = 7.60-9.39. The first two ranges are related to the dissociation of the two acid functions, while the third is related to pK a values of the basic -NH 2 function. A comparison of these data with the pK a values of Glu, Asp, and Gly 12 (Table 1) indicates that it is reasonable to assign the first and the second sets to the prevalent dissociation of the COOH function and of the hydroxyl-1,2,5-oxadiazole moiety, respectively. The third set is then assigned to the NH 3 þ group. At physiological pH, products 15 and 18 exist, similar to Glu and ASP, predominantly in the anionic tricharged form (--þ), while in 12, and partly in 10, this species is in equilibrium with the dianionic form (--).
At AMPA receptors, groups known to behave as bioisosters of the distal COOH function cover a pK a range where the ionized form predominates in aqueous solutions. 13 degree of ionization is expected to disfavor binding by shifting the equilibrium away from the presumably active form carrying three charges. The high degree of acidity exhibited by the hydroxyfurazan moiety should be favorable in this sense.
Chiral HPLC Resolution of Stereomers. The resolution of compounds 10, 12, 15, and 18 was performed on a Crownpak CR(þ) semipreparative column, using 15 mM aqueous acetic acid (pH 3.0) as the mobile phase. The stereochemical purity of each obtained enantiomer was >99%. For all the products the first eluted enantiomers were the levorotatory (-) ones. It is interesting to point out that the specific rotations [R] 25 D found for 10 and 15 are close to those of the corresponding thio analogues. 10, 15 On the basis of the observed elution order of corresponding thio analogues on the Crownpak column 10, 15 as well as the general elution order of a series of racemic R-amino acids, the first-eluting (-)-isomers of compounds 10, 15, and 18 are believed to possess R-configuration. 16 No acceptable resolution was achieved for compound 12 or its N-Boc protected derivative, although a number of chiral stationary phases and eluents were investigated. NMR experiments, performed in D 2 O studying the rate of deuterium exchange of the R-H in compound 12, showed that the R-H undergoes quick exchange, most likely too fast for a successful resolution of 12.
Radioligand Binding at iGluRs. The affinities of the racemates and the isolated enantiomers for native AMPA, KA, and NMDA receptor sites were determined in receptor binding assays at rat brain membrane preparations using the radioligands [ 3 Table 2 .
Compound 12 showed affinity and preference for NMDA receptors similar to that of NMDA itself and the corresponding 5-methyl-3-hydroxyisoxazole analogue, 20 whereas compounds 15 and 18 displayed affinities for both NMDA and AMPA, but not for KA, receptor sites. For compounds 15 and 18, the AMPA receptor affinity resided in the (þ)isomers, whereas all four 15 and 18 isomers showed affinity for NMDA receptor sites with the (-)-enantiomers being eutomers. For 15, the observed profile at ionotropic receptor sites was different from the corresponding hydroxythiadiazole analogue, which does not show measurable affinity for native iGluR sites. 15 Compound 10, the close analogue of Glu, not only displayed quite potent affinity for AMPA receptors similar to that of AMPA (1) and TDPA 10 (2) but also turned out to be an unselective iGluR ligand, although with some preference for AMPA receptors. The pharmacology profile of 10 is quite different from those of the corresponding 3-hydroxyisoxazole 21 and the corresponding hydroxythiadiazole 10 (2) analogues which interact selectively with the AMPA receptor subtype of iGluRs. At all three classes of native iGluRs the affinity of 10 was shown to reside mainly in the (þ)-isomer. Similar to TDPA, 10 the interaction of 10 with AMPA receptors showed low stereoselectivity, as (þ)-10 is only approximately 6 times more potent than the other enantiomer. Since the stereochemical purity of (-)-10 is very high (99.6% ee), the observed affinity at AMPA receptors is not caused by a stereochemical impurity. The lower affinity for NMDA and KA receptors prevents any quantitative comparison of stereoselectivity at these sites.
Furthermore, (þ)-and (-)-10 were evaluated in receptor binding at the cloned AMPA receptor iGluR2(R) o and KA receptors iGluR5(Q) 1b , iGluR6(V,C,R) A , and iGluR7 A ( Table 3) . At both iGluR2 and iGluR5 receptors (þ)-10 was the most potent isomer, being 6-and 10-fold more potent compared to (-)-10, respectively. (þ)-10 was demonstrated to be almost as potent as AMPA 22 at iGluR2 and iGluR5 but did not show any affinity for iGluR6 or iGluR7. Whereas (þ)-10 was more than 100-fold more potent at iGluR2 than at iGluR5 receptors, neither (þ)-15 nor (þ)-18 showed any preference for iGluR2 receptors.
Functional Studies at Representative Recombinant iGluRs. Active enantiomers were characterized functionally at selected AMPA and NMDA receptor subtypes ( Table 4 ). The concentration-response data of the stereoisomers and the calculated EC 50 values generally supported the affinity data reported in Table 3 . At iGluR2, (þ)-and (-)-10 as well as (þ)-15 and (þ)-18 turned out to be agonists ( Figure 2 ) with relative potencies to some extent in agreement with the affinities reported in Table 3 . Efficacy measurements conducted for (þ)-10 at iGluR2(Q) i indicated that the compound has an efficacy that was statistically significantly lower (paired t test, P = 0.037), 0.92 ( 0.03 (mean ( SEM, n = 8) relative to (S)-Glu (efficacy = 1.000).
Furthermore, enantiomers displaying affinity at native NMDA receptor sites were studied at NR1/NR2A receptors expressed in BHK-21 cells using intracellular calcium measurements. 23 (þ)-10 displayed a partial agonist profile ( Figure 3a and Table 4 ). The enantiomers of 15 and 18 were inactive when tested for agonistic activity. However, (-)-15 and (-)-18 behaved as antagonists with similar potencies (Figure 3b ). Also, the related (þ)-enantiomers showed antagonistic activity but their IC 50 values (Table 4) were markedly higher complementing the affinity data of Table 3 . It is interesting that the stereoselectivity of compound 15, with (-)-15 being the more potent isomer, is also seen with the corresponding hydroxythiadiazole analogue of 15, 15 although this compound is markedly less potent than (-)-15 at NMDA receptors.
Conclusions
The results reported in the present work show that the 4-hydroxy-1,2,5-oxadiazol-3-yl moiety, when incorporated in Asp and Glu-related compounds as well as the two higher homologues, gives rise to products that are uniquely recog-nized by iGluRs. Among the four new acidic amino acids, the strict Glu analogue 10 turned out to have a pharmacological profile very similar to that of Glu, being an unselective but AMPA-receptor preferring agonist, with EC 50 = 10 μM at iGluR2 and a relative efficacy of 0.92. At iGluR2, iGluR5, and NR1/NR2A, (þ)-10 was shown to be the eutomer. These results indicate that biomimetics of Asp, Glu, and their 50 ( SEM (shown in brackets) and the corresponding EC 50 values were calculated from full concentration-response curves. The mean relative maximal response (I/I max ( SEM) is relative to maximal steady-state currents evoked by (S)-Glu. The number of oocytes was between 5 and 13. b Parameters measured by [Ca 2þ ] i measurements. Mean pEC 50 ( SEM (shown in brackets) and the corresponding EC 50 values as well as relative F max ( SEM (relative to F max of (S)-Glu) (maximal response to glutamate, 1.0) were calculated from full concentration-response curves. For the agonist data the Hill coefficients were between 1.1 and 1.5, and the number of experiments was 3. Inhibition of NMDA receptor subtype, NR1-1a/NR2A, by increasing concentrations of antagonists was performed using 6 μM (S)-Glu. The mean pIC 50 ( SEM (shown in brackets) and the corresponding IC 50 values were calculated from full concentration-response curves. For all antagonist data, the number of experiments was 3. c nd: not determined. nr: no response to 1000 μM. homologues can be obtained by substitution of the distal carboxylic acid with the isoster 4-hydroxy-1,2,5-oxadiazol-3yl substructure.
Experimental Section
Chemistry. Melting points were determined on a B€ uchi 530 apparatus or an SRS Optimelt apparatus and are uncorrected. The compounds were routinely checked by mass spectrometry (Finnigan-MatTSQ-700 spectrometer, 70 eV, direct inlet). 1 H NMR spectra and proton decoupled 13 C NMR spectra were recorded on a Bruker AC-300 spectrometer. The following abbreviations are used to indicate peak multiplicity: s = singlet; d = doublet; dd = doublet of doublet; t = triplet; q = quartet; m = multiplet. Flash column chromatography was performed on silica gel (Merck Kieselgel 60, 230-400 mesh ASTM) using the indicated eluents. Thin layer chromatography (TLC) was carried out on 5 cm Â 20 cm plates with a layer thickness of 0.25 mm. When necessary, they were developed using UV light, iodine, KMnO 4 , and ninhydrin. Anhydrous magnesium sulfate was used as drying agent of the organic extracts. Elemental analyses of new compounds were within (0.4% of the theoretical values unless otherwise stated. The moisture sensitive reactions were performed under dry N 2 or Ar. Tetrahydrofuran (THF) was distilled immediately before use from sodium and benzophenone under nitrogen. Compounds 3 24 Liquid Chromatography. Semipreparative chiral HPLC of 10, 15, and 18 was performed on a Crownpak CR(þ) column (150 mm Â 10 mm, 5 μm) equipped with a Crownpak CR guard column (10 mm Â 4.0 mm, 5 μm) (Daicel Chemical Industries, Ltd., Japan) connected to a Jasco 880 pump, a Rheodyne 7125 injector, a 5 mL loop, a TSP UV100 detector (230 nm), and a Hitachi D-2000 Chromato-Integrator (Merck). The flow rate was 0.7 mL/min for 10 and 1.5 mL/min for 15 and 18. The column was kept at 0°C using an ice bath for compound 10, and elution was at room temperature for 15 and 18. The mobile phase was aqueous AcOH (15 mM).
Analytical chiral HPLC, used for the determination of enantiomeric excess (ee) of the enantiomers of 10, 15, and 18, was performed using a Crownpak CR(-) column (150 mm Â 4.0 mm, 5 μm) (Daicel Chemical Industries, Ltd., Japan). The column was eluted with aqueous AcOH (15 mM), and the flow-rate was 0.4 mL/min. The column was thermostated at 1°C for (þ)-and (-)-10 and at 10°C for (þ)-and (-)-15 and (þ)-and (-)-18 using a Hetofrig thermostat. A TSP HPLC system consisting of a P2000 pump, an AC 3000 autosampler, and an SM 5000 PDA detector was connected to the column.
Ethyl [4-(Benzyloxy)-1,2,5-oxadiazol-3-yl]acetate (4) . A solution of 3 (59.4 g, 412.3 mmol) in ethanol saturated with gaseous HCl (180 mL) was stirred at room temperature overnight. The mixture was concentrated under reduced pressure and the resulting crude material was purified by flash chromatography (eluent, CH 2 Cl 2 /EtOH (96% v/v), 9:1 v/v) to give the ethyl ester of 3 that was directly used in the next step without any further purification. K 2 CO 3 (70 g, 507.0 mmol) and benzyl bromide (30 mL, 251.95 mmol) were added to an acetone (600 mL) solution of the ester previously obtained. The resulting mixture was refluxed for 3 h and then filtered. The filtrate was concentrated under reduced pressure, obtaining an oil that was purified preliminarily by flash chromatography (eluent, petroleum ether (40-60°C)/EtOAc, 95:5 v/v) and then distilled (bp = 152°C at 2.4 Â 10 -2 mbar) to give 4 as colorless oil. Yield 75%. 1 [4-(Benzyloxy)-1,2,5-oxadiazol-3-yl]acetic Acid (4a). NaOH (6 M, 13 mL) was added over 20 min to a solution of 4 (17.0 g, 64.82 mmol) in ethanol (96%, 230 mL). The resulting suspension was concentrated under reduced pressure, and the residue was dissolved in water (120 mL). The solution was acidified with 6 M HCl and then extracted with dichloromethane (2 Â 150 mL). The organic layers were collected, dried, and concentrated under reduced pressure to obtain pure 4a as a white solid (mp 101-102°C from diisopropyl ether/hexane, 7:3 v/v). Yield 88%. 1 4-(Benzyloxy)-1,2,5-oxadiazole-3-carboxylic Acid (5). KMnO 4 (12.28 g, 77.72 mmol) was added portionwise over 15 min to an ice cooled solution of 4a (9.1 g, 38.96 mmol) in acetone (90 mL). The reaction mixture was stirred at room temperature for 40 min and then poured into 2 M HCl (90 mL). The resulting mixture was filtered, and the solid residue was extensively washed with dichloromethane. The aqueous layer was extracted with dichloromethane (2 Â 80 mL), and the organic layers were collected, dried, and concentrated under reduced pressure to give 5 as a white solid (mp 106-107°C from hexane/diisopropyl ether). Yield 71%. 1 Methyl 4-(Benzyloxy)-1,2,5-oxadiazole-3-carboxylate (6). A solution of 5 (7.10 g, 32.25 mmol) in methanol saturated with HCl (160 mL) was stirred at room temperature over 20 h and then concentrated under reduced pressure. The residue was treated with a saturated solution of NaHCO 3 (60 mL), and the resulting mixture was extracted with diethyl ether (4 Â 50 mL). The organic layers were collected, dried, and concentrated under reduced pressure to give 6 as a white solid (mp 45-46°C from hexane). Yield 73%. 1 [4-(Benzyloxy)-1,2,5-oxadiazol-3-yl]methanol (7) . NaBH 4 (2.59 g, 68.32 mmol) was added portionwise over 15 min to a solution of 6 (4.00 g, 17.08 mmol) in dry ethanol (100 mL), and the mixture was stirred under inert atmosphere at room temperature. After 1 h, the reaction mixture was poured into iced water (300 mL). The resulting mixture was extracted with diethyl ether (2 Â 100 mL). The organic layers were collected, dried, and concentrated under reduced pressure. The residue was purified by flash chromatography (eluent, dichloromethane) to afford 7 as a colorless oil. Yield 73%. 1 (20 mL). The reaction mixture was directly loaded onto a flash chromatography column (eluent, dichloromethane) to give 8 as a white solid (mp 37-38°C triturated from diisopropyl ether). Yield 88%. 1 (9) . NaH (60% w/w, 535 mg, 13.38 mmol) was added portionwise to an ice cooled solution of diethyl [(tert-butoxycarbonyl)amino]malonate (3.68 g, 13.38 mmol) in dry THF (45 mL) kept under inert atmosphere. The reaction mixture was stirred at room temperature for 1 h, and then a solution of 8 (3.00 g, 11.15 mmol) in dry THF (13 mL) was added over 15 min. The resulting mixture was stirred at room temperature for 18 h and then poured into a saturated solution of NH 4 Cl (150 mL). The resulting mixture was extracted with diethyl ether (100 þ 50 mL). The organic layers were collected, dried, and concentrated under reduced pressure to afford a solid white material. The crude material was triturated with diisopropyl ether to afford pure 9 as a white solid (mp 111-112°C). Yield 94%. 1 Diethyl [(tert-Butoxycarbonyl)amino][(4-hydroxy-1,2,5-oxadiazol-3-yl)methyl]malonate (9a). Pd/C (10% w/w, 750 mg) was added to a solution of 9 (4.63 g, 9.99 mmol) in dry THF (90 mL). The resulting mixture was vigorously stirred at room temperature under hydrogen for 1 h. The resulting mixture was filtered on Celite, and the filtrate was concentrated under reduced pressure. The crude material was triturated with diisopropyl ether to afford pure 9a as a white solid (mp 145-146°C from diisopropyl ether). Yield 59%. 1 (RS)-2-Amino-3-(4-hydroxy-1,2,5-oxadiazol-3-yl)propionic Acid (10) . A suspension of 9a (2.00 g, 5.36 mmol) in hydrobromic acid (48% w/w, 50 mL) was refluxed for 24 h and then concentrated under reduced pressure. The crude material was triturated with dry EtOAc and dissolved in water (26 mL, 5% w/w). The solution was percolated on IRA400 (conditioned with 1 M AcOH) using water as eluent until neutrality and then with AcOH (from 1 to 3 M). The ninhydrin positive fractions were collected and concentrated under reduced pressure. The resulting crude material was finally purified by trituration with water to afford pure 10 as a white solid (mp 205-206°C dec from water). Yield 53%. 1 H NMR (D 2 O) δ 3.14-3.28 (m, 2H, -CH 2 CH-), 4.10 (dd, J = 5.7 Hz, J = 6.8 Hz, 1H, -CH 2 CH-). 13 The collected fractions of the first eluting peak were pooled, evaporated, re-evaporated three times from water, and dried in vacuo to give (-)-10 (mp 175-176°C dec). Yield (119 mg, 95%). (C 5 H 7 N 3 O 4 3 0.2 H 2 O) C, H, N. The collected fractions of the second eluting peak were pooled, evaporated, re-evaporated three times from water, and dried in vacuo to give (þ)-10 (mp 176-177°C dec). Yield (117 mg, 95%). 1 H NMR spectrum of (þ)-10 was identical to that of (-)-10. ee = 98.9%. Ethyl 2-[4-(Benzyloxy)-1,2,5-oxadiazol-3-yl](hydroxyimino)acetate (11) . A solution of 4 (5.00 g, 19.03 mmol) in dry ethanol (60 mL) was added over 5 min to a cooled (0°C) solution of NaH (60% w/w, 913 mg, 22.8 mmol) in dry ethanol (75 mL), kept under inert atmosphere. The mixture was stirred at 0°C for 30 min, and then an ethanolic solution of EtONO (15% w/w, 24 mL, 38.2 mmol) was added dropwise. The reaction mixture was allowed to reach room temperature and then stirred for 20 h. After addition of glacial acetic acid (1.3 mL), the mixture was poured into water (250 mL). The resulting mixture was extracted with diethyl ether (3 Â 100 mL). The organic layers were collected, dried, and concentrated under reduced pressure. The resulting crude material was purified by flash chromatography (eluent, petroleum ether (40-60°C)/EtOAc, 8:2 v/v) to afford 11 as a white solid as a pure mixture of the two geometrical isomers in variable ratio. Yield 85%. 1 (RS)-2-Amino-(4-hydroxy-1,2,5-oxadiazol-3-yl)acetic Acid (12) . A solution of 11a (760 mg, 2.01 mmol) in 6 M HCl (30 mL) was stirred at 70°C for 4 h. The resulting mixture was concentrated under reduced pressure. The crude material was purificated by trituration with water to afford pure 12 as a white solid (mp 156-158°C dec from water). Yield 86%. 1 2-[4-(Benzyloxy)-1,2,5-oxadiazol-3-yl]ethanol (13) . LiAlH 4 (2.60 g, 68.49 mmol) was added over 150 min to a cooled (-50°C) solution of 4 (11.0 g, 41.94 mmol) in dry THF (65 mL) kept under inert atmosphere. The reaction mixture was stirred at -50°C for 14 h, then allowed to reach room temperature and poured into ice cooled 2 M HCl (160 mL). The resulting mixture was extracted with diethyl ether (2 Â 100 mL). The organic layers were collected, dried, and concentrated under reduced pressure to afford a crude solid material which was purified by flash chromatography (eluent, petroleum ether (40-60°C)/EtOAc, 8:2 v/ v), obtaining 13 as a white solid (mp 47-48°C triturated from diisopropyl ether). Yield 53%. 1 Diethyl [(tert-Butoxycarbonyl)amino][2-(4-(benzyloxy)-1,2,5oxadiazol-3-yl)ethyl]malonate (14) . Triflic anhydride (1.95 mL, 11.8 mmol, 1.3 equiv) was added over 1 h to a solution of 13 (2,00 g, 9.08 mmol) and 2,6-lutidine (1.27 mL, 10.90 mmol) in dry dichloromethane (50 mL), and the mixture was stirred under inert atmosphere at -45°C. The reaction mixture was allowed to reach room temperature and then stirred for 1 h. The reaction mixture was directly loaded onto a flash chromatography column (eluent, dichloromethane) to give the moisture sensitive trifluoromethylsulfonyl derivative of 13 as a colorless oil in acceptable purity to be used immediately in the next step. NaH (60% w/w, 400 mg, 9.99 mmol) was added portionwise to an ice cooled solution of diethyl [(tert-butoxycarbonyl)amino]malonate (2.75 g, 9. 99 mmol) in dry THF (40 mL) kept under inert atmosphere. The mixture was stirred at room temperature for 1 h, and then a solution in dry dichloromethane (50 mL) of the triflate, obtained in the previous step, was slowly added. The mixture was stirred for 15 h and then poured into a saturated solution of NH 4 Cl (100 mL). The aqueous layer was extracted with dichloromethane (100 mL). The organic layers were collected, dried, and concentrated under reduced pressure. The crude material was purified by flash chromatography (eluent, petroleum ether (40-60°C)/EtOAc, 9:1 v/v) to afford 14 as a white solid (mp 62°C from hexane/diisopropyl ether, 5:1 v/v). Yield 73%. 1 (RS)-2-Amino-4-(4-hydroxy-1,2,5-oxadiazol-3-yl)butanoic Acid (15) . A suspension of 14a (1.28, 3.29 mmol) in hydrobromic acid (48% w/w, 30 mL) was refluxed for 24 h and then concentrated under reduced pressure. The resulting crude solid material was triturated with dry EtOAc and then dissolved in water (26 mL, 5% w/w). The solution was percolated on IRA400 (conditioned with 1 M AcOH) using water as eluent until neutrality and then aqueous AcOH (from 1 to 3 M). Ninhydrin positive fractions were collected and concentrated under pressure. The resulting crude material was triturated with water to afford 15 as a white solid (mp 202°C dec from water). Yield 70%. 1 The collected fractions of the first eluting peak were pooled, evaporated, re-evaporated three times from water, and dried in vacuo to give (-)-15 (mp 176-177°C dec). Yield (122 mg, 98%). (17) . Triflic anhydride (2.22 mL, 13.42 mmol) was added to a solution of 16 (3.00 g, 11.18 mmol) and 2,6-lutidine (1.56 mL, 13.42 mmol) in dry dichloromethane (60 mL) cooled (-45°C) under inert atmosphere. The reaction mixture was allowed to reach room temperature and then stirred for 1 h. The reaction mixture was then loaded onto a flash chromatography column (dichloromethane), obtaining the moisture sensitive trifluoromethansulfonate of 16 as colorless oil in acceptable purity to be used immediately in the next step. NaH (60% w/w, 492 mg) was added portionwise to a solution of diethyl [(tert-butoxycarbonyl)amino]malonate (3.39 g, 12.30 mmol) in dry THF (24 mL), kept under inert atmosphere. The mixture was stirred at room temperature for 1 h. Then a solution of triflate, obtained in the previous step, in dry dichloromethane (60 mL) was added over 1.5 h. The reaction mixture was stirred at room temperature and then poured into a saturated solution of NH 4 Cl (100 mL). The resulting mixture was extracted with dichloromethane (100 þ 20 mL), and the collected organic layers were dried and concentrated under reduced pressure. The residue was purified by flash chromatography (eluent, petroleum ether (40-60°C)/diisopropyl ether, 1:1 v/v) to give a crude that by trituration with EtOH (96% w/w) afforded pure 17 as a white solid (mp 78°C from hexane/diisopropyl ether, 5:1 v/v). Yield 43%. 1 (RS)-2-Amino-5-(4-hydroxy-1,2,5-oxadiazol-3-yl)pentanoic Acid (18). NaOH (5 M, 8 mL) was added to a solution of 17 (1.046 g, 1.99 mmol) in DMSO (8 mL). The reaction mixture was heated at 70°C for 2 h, diluted with water (10 mL), and neutralized with 6 M HCl until pH 7.5 was obtained. Oxone (2.43 g, 3.95 mmol) was added to the mixture, maintaining the pH near 1.7 by adding 2 M NaOH. The resulting mixture was filtered, and the filtrate was extracted with diethyl ether (20 mL Â 13). The organic layers were collected, dried, and concentrated under reduced pressure. The crude material was dissolved in hydrobromic acid (48% w/w, 15 mL), and the resulting solution was refluxed for 72 h. The mixture was concentrated under reduced pressure, and the resulting residue was dissolved in water. After repeating this step three times, the resulting crude material was triturated with dry EtOAc. The obtained crude solid was dissolved in water (7 mL) and the resulting solution was percolated on IRA400 (conditioned with 1 M AcOH) using water as eluent until neutrality was obtained and then aqueous AcOH (from 1 to 3 M). Ninhydrin positive fractions were collected and concentrated under reduced pressure. Trituration with water of the resulting crude material afforded pure 18 as a white solid (mp 200-202°C dec, from water). Yield 47%. 1 equation and plotted together with the resulting curve. Antagonist concentration-response data were calculated using a similar protocol, where instead of calculating the EC 50 value, the concentration required to inhibit a response induced by 6 μM (S)-Glu by 50% (IC 50 ) was calculated.
